Study: Grant 2025, Journal of the American Academy of Dermatology

Disparities in acral lentiginous melanoma: Factors beyond delayed diagnosis

Citation

Grant S, Revan D, Tang L et al (2025). Journal of the American Academy of Dermatology. PubMed id 40562077.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Skin cancer and moles on dark skin Tier B moderate

    B Cutaneous melanoma cases in SEER compared by race (n=not stated)

    Registry cohort.

    No significant difference in disease severity at diagnosis between Black and White patients with acral lentiginous melanoma, yet Black patients had double the risk of dying from it (hazard ratio 2.04). The authors say delay in diagnosis does not fully explain the gap.

    As recorded in this card: Grant S, Revan D, Tang L et al (2025), Journal of the American Academy of Dermatology, [primary]

    Note: Counters the simple "found late" story for acral melanoma.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.